Related Experiment Video
Updated: Aug 11, 2026

Quantitative Assessment of Immune Cells in the Injured Spinal Cord Tissue by Flow Cytometry: a Novel Use for a Cell Purification Method
Published on: April 9, 2011
Altered Circulating Immune Cell Distribution in Traumatic Spinal Cord Injury Patients in Relation to Clinical
Judith Fraussen1, Lien Beckers1, Charlotte C M van Laake-Geelen2,3
1Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, Hasselt, Belgium.
Insights
Spinal cord injury (SCI) triggers inflammation, altering immune cells. This study found memory B cells and CD74 expression are key in SCI, offering potential biomarkers for disease severity and neuroinflammation.
Area of Science:
- Immunology
- Neuroscience
- Cell Biology
Background:
- Spinal cord injury (SCI) initiates an inflammatory cascade, leading to secondary tissue damage.
- The systemic immune response following SCI remains incompletely understood.
- Understanding immune cell dynamics is crucial for managing SCI outcomes.
Purpose of the Study:
- To comprehensively analyze circulating immune cell composition in traumatic SCI patients.
- To correlate immune cell profiles with clinical parameters and disease severity.
- To investigate the role of specific immune cell subsets and markers in SCI pathogenesis.
Main Methods:
- High-dimensional flow cytometry was employed on peripheral blood mononuclear cells.
- Samples were analyzed from 18 traumatic SCI patients and 18 healthy controls.
- Immune cell subsets were quantified at (sub)acute and chronic SCI phases.
Main Results:
- Increased total and CD4+ T cell frequencies were observed in chronic SCI (cSCI) patients.
- Both CD4+ T cells and B cells exhibited a shift towards memory phenotypes post-SCI.
- Significant alterations in the B cell compartment included decreased IgG+ and increased IgM+ frequencies, correlating with American Spinal Injury Association (ASIA) impairment scale (AIS) scores.
- Increased CD74+ cells and CD74 expression were noted on B cells in SCI patients.
Conclusions:
- Post-SCI inflammation appears to be driven by memory immune cell subsets.
- Elevated CD74 expression on B cells suggests potential involvement of CD74-related pathways in neuroinflammation.
- Circulating IgM+ and IgG+ B cell levels may hold prognostic value for SCI patients.
Abstract:
Following a spinal cord injury (SCI), an inflammatory immune reaction is triggered which results in advanced secondary tissue damage. The systemic post-SCI immune response is poorly understood. This study aimed to extensively analyse the circulating immune cell composition in traumatic SCI patients in relation to clinical parameters. High-dimensional flow cytometry was performed on peripheral blood mononuclear cells of 18 traumatic SCI patients and 18 healthy controls to determine immune cell subsets. SCI blood samples were collected at multiple time points in the (sub)acute (0 days to 3 weeks post-SCI, (s)aSCI) and chronic (6 to >18 weeks post-SCI, cSCI) disease phase. Total and CD4+ T cell frequencies were increased in cSCI patients. Both CD4+ T cells and B cells were shifted towards memory phenotypes in (s)aSCI patients and cSCI patients, respectively. Most profound changes were observed in the B cell compartment. Decreased immunoglobulin (Ig)G+ and increased IgM+ B cell frequencies reflected disease severity, as these correlated with American Spinal Injury Association (ASIA) impairment scale (AIS) scores. Post-SCI B cell responses consisted of an increased frequency of CD74+ cells and CD74 expression level within total B cells and B cell subsets. Findings from this study suggest that post-SCI inflammation is driven by memory immune cell subsets. The increased CD74 expression on post-SCI B cells could suggest the involvement of CD74-related pathways in neuroinflammation following SCI. In addition, the clinical and prognostic value of monitoring circulating IgM+ and IgG+ B cell levels in SCI patients should be further evaluated.
More Related Videos
Related Concept Videos
Spinal Cord Injury ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology

